Research and Development (R&D) plays a crucial role in Microcore's vision and strategy since its incorporation in 2007. R&D is stated as a fundamental part of Microcore's vision and strategy right from its inception in 2007. This implies that the company places a strong emphasis on innovation and staying at the forefront of technological advancements in biotechnology.
Microcore leverages its expertise in biotechnology to create novel processes and develop new molecules specifically in the field of nutraceuticals. This suggests a focus on health and wellness products derived from natural sources. Microcore highlights its commitment to continuous investment in R&D. This ongoing investment is crucial for staying ahead of the curve, adapting to industry changes, and ensuring the development of cutting-edge solutions.
Innovative Processes, Products, Technologies, and IPR: The outcome of Microcore's R&D efforts includes the development of innovative processes, products, technologies, and Intellectual Property Rights (IPR). This suggests a holistic approach to innovation, covering various aspects that contribute to the company's success and differentiation in the market.
In-house R&D has been recognized by the Department of Scientific and Industrial Research (DSIR) in the Government of India. This acknowledgment reflects the quality and significance of your research efforts.
Your approach of defining core competencies aligned with major technology platforms, especially in the field of Nutraceuticals, showcases a strategic focus. Being able to apply these competencies to product development, process technologies, and scale-up indicates a comprehensive approach to innovation. The S2B (Science to Business) and B2S (Business to Science) approach you've mentioned is an effective strategy. Transitioning knowledge and insights from scientific research to practical business applications and vice versa helps bridge the gap between theoretical advancements and market demands. This not only demonstrates a strong understanding of market dynamics but also positions your organization well to meet industry needs.
Microcore's multi-disciplinary team, including scientists, engineers and business development professionals, have an outstanding track record in turning science into commercially attractive, nutritional solutions, constantly enriching our unique cluster of technology and expertise. Some of our pipeline product includes:
Microcore has a robust focus on microbial research and development, particularly in the field of microbiome modulators and their applications in preventing and managing chronic lifestyle diseases. Your proprietary collection of over 3000 micro-organisms, along with a strain and molecule database for probiotics, enzymes, and biotransformation, highlights a comprehensive approach to discovering and screening microbial strains.
The emphasis on classical mutation and molecular biology as core competencies for strain and yield development suggests a sophisticated understanding of genetic and molecular mechanisms. This foundation likely plays a crucial role in Microcore's ability to identify and develop microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds with potential health benefits.
Next-generation probiotic that aids soft and nutritious idli fermentation.
Produces fruity aroma (pine apple and jack fruit flavor) flavoring agents in food preparations. Next-generation probiotic that aids soft and nutritious idli fermentation.
Aids elements of cardiovascular wellbeing. Modulates bile acid metabolism beneficial for heart health factors, liver function, glucose regulation, and vitamin metabolism.
Boosts production of the major cellular antioxidant glutathione.
Works for bone health (osteoporosis prevention), sports nutrition, and dental health. Stimulates calcium absorption and transport by intestinal cells.
Microcore's commitment to scientific rigor is evidenced by our extensive list of publications across international medical and biotechnology journals. These peer-reviewed works validate our research methodologies and product efficacy.
1. A randomized, open-label, multicentered parallel-group clinical study to evaluate the efficacy and safety of Joint Core® compared to Jointace DN® in osteoarthritis patients. (2022 Journal of Current Research in Scientific Medicine)
Journal Download2. Comparative evaluation of bioavailability, efficacy and safety of Microcore NESC® with calcium carbonate and calcium citrate malate in osteopenic and osteoporotic patients. (Indian Journal of Orthopaedics, 2024)
3. Journal of Dermatology Research Reviews & Reports: TRICHOVITALS® OVERVIEW, HAIR | SKIN | NAIL - Wellness.
View Publication4. Evaluating Safety and Efficacy Comparison of Different Composition of Eggshell Membrane Vs Nanoparticles Egg Shell Membrane Along with Nanoparticle Extract of Boswellia Serrata and Curcumin for Treatment of Osteoarthritis in Rat Models. (2026)
View Publication1. Formulation, characterization and antibacterial activity evaluation of collagen based Silver nanoparticle. (IJPSR 2020)